Stocktoria

LIXTE BIOTECHNOLOGY HOLDINGS, INC. LIXT

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2007-09-21 · LEI

LIXTE BIOTECHNOLOGY HOLDINGS, INC. statistics & valuation

Market cap$125.0M
P / B11.4×
Return on equity-55.5%
Return on capital-44.8%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
2016201720182019202020212022202320242025
Return on equity (%)
-994.00% -181.70% -51.70% -100.30% -65.10% -140.50% -122.20% -127.30% -433.50% -55.50% 2016201720182019202020212022202320242025
Shares outstanding
47.9M 58.0M 67.0M 11.2M 12.4M 13.7M 1.7M 2.2M 2.2M 8.8M 2016201720182019202020212022202320242025
Net debt ($)
2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-492.50% -132.20% -49.20% -91.30% -62.40% -132.10% -113.50% -118.10% -313.00% -47.70% 2016201720182019202020212022202320242025
Free cash flow margin (%)
2016201720182019202020212022202320242025
Debt / equity (×)
2016201720182019202020212022202320242025
EPS ($)
-$3.99 -$2.66 -$1.59 -$1.26 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Return on assets-47.7%-313.0%-118.1%-113.5%-132.1%-62.4%-91.3%-49.2%-132.2%-492.5%
Return on equity-55.5%-433.5%-127.3%-122.2%-140.5%-65.1%-100.3%-51.7%-181.7%-994.0%
Current ratio3.883.6013.7314.0516.8124.1511.2320.553.671.98

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.